Hie, Miguel <br/><br/>
Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura.  [electronic resource] 

 -  Blood  Jul 2014 
 - 204-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2014-01-550244  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADAM Proteins--blood<br/>ADAMTS13 Protein<br/>Adult<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Autoantibodies--blood<br/>Chemoprevention--methods<br/>Cross-Sectional Studies<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Purpura, Thrombotic Thrombocytopenic--blood<br/>Remission Induction<br/>Retrospective Studies<br/>Rituximab<br/>Secondary Prevention<br/>Treatment Outcome